These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1868872)

  • 1. Preferential development of pre-B lymphomas with drastically down-regulated N-myc in the E mu-ret transgenic mice.
    Iwamoto T; Pu M; Ito M; Takahashi M; Isobe K; Nagase F; Kawashima K; Ichihara M; Nakashima I
    Eur J Immunol; 1991 Aug; 21(8):1809-14. PubMed ID: 1868872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival and death of prelymphomatous B-cells from N-myc/bcl-2 double transgenic mice correlates with the regulation of intracellular Ca2+ fluxes.
    Zörnig M; Busch G; Beneke R; Gulbins E; Lang F; Ma A; Korsmeyer S; Möröy T
    Oncogene; 1995 Nov; 11(10):2165-74. PubMed ID: 7478538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E mu N- and E mu L-myc cooperate with E mu pim-1 to generate lymphoid tumors at high frequency in double-transgenic mice.
    Möröy T; Verbeek S; Ma A; Achacoso P; Berns A; Alt F
    Oncogene; 1991 Nov; 6(11):1941-8. PubMed ID: 1658705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MHC class I expression on prelymphomatous and lymphomatous B-cells is not inhibited by an E mu-myc transgene.
    Algarra I; Silva S; Ljunggren HG
    Eur J Cancer; 1993; 29A(2):238-41. PubMed ID: 8422288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. bmi-1 transgene induces lymphomas and collaborates with myc in tumorigenesis.
    Haupt Y; Bath ML; Harris AW; Adams JM
    Oncogene; 1993 Nov; 8(11):3161-4. PubMed ID: 8414519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2.
    Strasser A; Harris AW; Bath ML; Cory S
    Nature; 1990 Nov; 348(6299):331-3. PubMed ID: 2250704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular requirements for rapid plasmacytoma and pre-B lymphoma induction by Abelson murine leukemia virus in myc-transgenic mice.
    Sugiyama H; Wang Y; Jackson P; Sawyers CL; Klein G
    Int J Cancer; 1994 Jul; 58(1):135-41. PubMed ID: 8014009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice.
    Park SS; Kim JS; Tessarollo L; Owens JD; Peng L; Han SS; Tae Chung S; Torrey TA; Cheung WC; Polakiewicz RD; McNeil N; Ried T; Mushinski JF; Morse HC; Janz S
    Cancer Res; 2005 Feb; 65(4):1306-15. PubMed ID: 15735016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface IgM mediated regulation of RAG gene expression in E mu-N-myc B cell lines.
    Ma A; Fisher P; Dildrop R; Oltz E; Rathbun G; Achacoso P; Stall A; Alt FW
    EMBO J; 1992 Jul; 11(7):2727-34. PubMed ID: 1628630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ret oncogene products are membrane-bound glycoproteins phosphorylated on tyrosine residues in vivo.
    Taniguchi M; Iwamoto T; Hamaguchi M; Matsuyama M; Takahashi M
    Biochem Biophys Res Commun; 1991 Nov; 181(1):416-22. PubMed ID: 1958211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evolution of B precursor leukemia in the Emu-ret mouse.
    Wasserman R; Zeng XX; Hardy RR
    Blood; 1998 Jul; 92(1):273-82. PubMed ID: 9639527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogene-linked in situ immunotherapy of pre-B lymphoma arising in E mu/ret transgenic mice.
    Ichihara M; Iwamoto T; Isobe K; Takahashi M; Nakayama A; Pu M; Dai Y; Parashar A; Ohkus K; Kato M
    Br J Cancer; 1995 Apr; 71(4):808-13. PubMed ID: 7710948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice.
    Lovec H; Grzeschiczek A; Kowalski MB; Möröy T
    EMBO J; 1994 Aug; 13(15):3487-95. PubMed ID: 8062825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An E mu-v-abl transgene elicits plasmacytomas in concert with an activated myc gene.
    Rosenbaum H; Harris AW; Bath ML; McNeall J; Webb E; Adams JM; Cory S
    EMBO J; 1990 Mar; 9(3):897-905. PubMed ID: 2155783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic N-myc mouse model for indolent B cell lymphoma: tumor characterization and analysis of genetic alterations in spontaneous and retrovirally accelerated tumors.
    Sheppard RD; Samant SA; Rosenberg M; Silver LM; Cole MD
    Oncogene; 1998 Oct; 17(16):2073-85. PubMed ID: 9798678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transgenic window on lymphoid malignancy.
    Adams JM; Harris AW; Vaux DL; Alexander WS; Rosenbaum H; Klinken SP; Strasser A; Bath ML; McNeall J; Cory S
    Princess Takamatsu Symp; 1989; 20():297-309. PubMed ID: 2518688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.
    Eischen CM; Weber JD; Roussel MF; Sherr CJ; Cleveland JL
    Genes Dev; 1999 Oct; 13(20):2658-69. PubMed ID: 10541552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linkage between melanocytic tumor development and early burst of Ret protein expression for tolerance induction in metallothionein-I/ret transgenic mouse lines.
    Kato M; Liu W; Akhand AA; Dai Y; Ohbayashi M; Tuzuki T; Suzuki H; Isobe K; Takahashi M; Nakashima I
    Oncogene; 1999 Jan; 18(3):837-42. PubMed ID: 9989837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-myc transgene promotes B lymphoid proliferation, elicits lymphomas and reveals cross-regulation with c-myc.
    Rosenbaum H; Webb E; Adams JM; Cory S; Harris AW
    EMBO J; 1989 Mar; 8(3):749-55. PubMed ID: 2785918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The c-myc oncogene perturbs B lymphocyte development in E-mu-myc transgenic mice.
    Langdon WY; Harris AW; Cory S; Adams JM
    Cell; 1986 Oct; 47(1):11-8. PubMed ID: 3093082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.